| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/23/2014 | US20140023667 Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| 01/23/2014 | US20140023666 Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof |
| 01/23/2014 | US20140023665 Novel maytansinoid derivatives with sulfoxide linker |
| 01/23/2014 | US20140023658 Regulating il-4 and il-3 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
| 01/23/2014 | US20140023654 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 01/23/2014 | US20140023653 Boldine derivatives for promoting bone growth |
| 01/23/2014 | US20140023646 Compositions and Methods for Treating Viral Infection |
| 01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
| 01/23/2014 | US20140023640 Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapy |
| 01/23/2014 | US20140023636 Aminocarboxylic acid derivative and medicinal use thereof |
| 01/23/2014 | US20140023634 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha |
| 01/23/2014 | US20140023627 Topical co-enzyme q10 formulations and methods of use |
| 01/23/2014 | US20140023619 Viral vector targeting cancer stem cells |
| 01/23/2014 | US20140023616 Macrocyclic inhibitors of flaviviridae viruses |
| 01/23/2014 | US20140023614 Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 01/23/2014 | US20140023611 Compounds and methods for inhibiting phosphate transport |
| 01/22/2014 | EP2687532A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these |
| 01/22/2014 | EP2687531A1 Tetrahydrocarboline derivative |
| 01/22/2014 | EP2687215A1 Mesterolone pharmaceutical composition for androgens' deficiencies in woman |
| 01/22/2014 | EP2687210A1 Stimulators and activators of soluble guanylate cyclase for use in the treatment of sickle cell anaemia and preservation of blood substitutes |
| 01/22/2014 | EP2686429A1 Compositions, process of preparation of said compositions and method of treating inflammatory diseases |
| 01/22/2014 | EP2686008A1 Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence |
| 01/22/2014 | EP2685988A2 Methods of treating breast cancer with anthracycline therapy |
| 01/22/2014 | EP2685977A1 COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE |
| 01/22/2014 | EP2685970A1 Composition comprising a diindolylmethane and a retinoid to treat a skin condition |
| 01/22/2014 | EP2685962A1 Topical nitric oxide systems and methods of use thereof |
| 01/22/2014 | EP2685823A1 Treatment of cancer |
| 01/22/2014 | EP2488170B1 Compositions comprising tramadol and celecoxib in the treatment of pain |
| 01/22/2014 | CN103533961A Method for egfr directed combination treatment of cancer |
| 01/22/2014 | CN103533960A C-kit antibodies and uses thereof |
| 01/22/2014 | CN103533932A (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one (compound a) for treatment |
| 01/22/2014 | CN103520726A Preparation method of invisible thermosensitive liposome as well as application of drug delivery system of invisible thermosensitive liposome in tumor treatment drugs |
| 01/22/2014 | CN103520725A Medicinal composition for treating emesis |
| 01/22/2014 | CN103520724A Novel application of inhibitor for protein HSD17B13 or coding genes thereof |
| 01/22/2014 | CN103520723A Oxaliplatin medicinal composition and application thereof |
| 01/22/2014 | CN103520722A Application of miR-17-5p and miR-20a in preparation of etoposide drug-resistant reversal agent |
| 01/22/2014 | CN103520721A Application of P2X7 antagonist oxATP in preparation of medicament for treating myocardial ischemia injuries and hypertension/sympathetic nervous system diseases |
| 01/22/2014 | CN103520137A Compound teriflunomide transdermal patch for treating rheumatic arthritis, and preparation method thereof |
| 01/22/2014 | CN102018657B Solid dispersoid containing progestational hormone, preparation method thereof and composite comprising same |
| 01/21/2014 | US8633277 Methods for forming polymer-drug conjugates |
| 01/21/2014 | US8633236 Compounds, compositions and methods |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8632801 Stable therapeutic formulations |
| 01/21/2014 | US8632787 Methods using immunomodulatory compounds for treatment of certain leukemias |
| 01/21/2014 | US8632750 Methods for recommending neurophysiological disorder therapy |
| 01/21/2014 | CA2628747C Combinations of hormone therapy agents and metalloprotease inhibitors for the treatment of cancer |
| 01/21/2014 | CA2550309C Canine probiotic bifidobacteria pseudolongum |
| 01/21/2014 | CA2550307C Canine probiotic bifidobacteria globosum |
| 01/21/2014 | CA2486473C Vaginal care composition |
| 01/21/2014 | CA2446723C Antibodies that immunospecifically bind to trail receptors |
| 01/21/2014 | CA2418014C Immunotherapy for chronic myelocytic leukemia |
| 01/21/2014 | CA2371995C Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 01/16/2014 | WO2014012007A2 Rspo3 binding agents and uses thereof |
| 01/16/2014 | WO2014012000A2 No-releasing guanidine-coxib anti-cancer agents |
| 01/16/2014 | WO2014011926A1 Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| 01/16/2014 | WO2014011663A1 Inhibitors of bacterial diguanylate cyclase |
| 01/16/2014 | WO2014011220A2 A method of treating androgen receptor (ar)-positive breast cancers with selective androgen receptor modulator (sarms) |
| 01/16/2014 | WO2014010654A2 Sulfonamide compound combination |
| 01/16/2014 | WO2014010603A1 Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed incontinence, and method for screening compounds to be included in said pharmaceutical composition |
| 01/16/2014 | WO2014010206A1 Immune tolerance inducer |
| 01/16/2014 | WO2014009349A1 Use of thiosulphate in order to potentiate the anti-pathogen effect of lactobacillus |
| 01/16/2014 | WO2013177187A3 Synergistic tumor treatment with extended-pk il-2 and therapeutic agents |
| 01/16/2014 | WO2009046535A8 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 01/16/2014 | US20140018433 Method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms) |
| 01/16/2014 | US20140018430 Novel composition for the treatment of cystic fibrosis |
| 01/16/2014 | US20140018415 Enhancing Autophagy or Increasing Longevity by Administration of Urolithins or Precursors Thereof |
| 01/16/2014 | US20140018403 No-releasing guanidine-coxib anti-cancer agents |
| 01/16/2014 | US20140018400 Methods and compositions related to neuroactive thiazoline compounds |
| 01/16/2014 | US20140018396 Combination of sulfonamide compound |
| 01/16/2014 | US20140018384 Quinolinone derivatives for use in the treatment of an autoimmune disease and/or an inflammatory disease |
| 01/16/2014 | US20140018383 Myeloid differentiation inducing agents |
| 01/16/2014 | US20140018374 Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors |
| 01/16/2014 | US20140018371 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| 01/16/2014 | US20140018352 Compounds useful as protein kinase inhibitors |
| 01/16/2014 | US20140018350 Combination of sulfonamide compound and tafluprost |
| 01/16/2014 | US20140018344 Azaindole derivatives |
| 01/16/2014 | US20140018342 Gamma secretase inhibitors |
| 01/16/2014 | US20140018335 Indole derivative, and pharmacologically acceptable salt thereof |
| 01/16/2014 | US20140018331 Methods for the treatment or prophylaxis of thrombosis or embolism |
| 01/16/2014 | US20140018330 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea |
| 01/16/2014 | US20140018327 Pyrrole Derivatives as Nicotinic Acetylcholine Receptor Modulators for Use in the Treatment of Neurodegenerative Disorders Such as Alzheimer's and Parkinson's Disease |
| 01/16/2014 | US20140018326 Sulfonamides as hib protease inhibitors |
| 01/16/2014 | US20140018321 Imidazole prodrug lxr modulators |
| 01/16/2014 | US20140018319 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 01/16/2014 | US20140018313 Antiviral compounds |
| 01/16/2014 | US20140018310 COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY |
| 01/16/2014 | US20140018291 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides |
| 01/16/2014 | US20140018289 New treatments of Hepatitis C virus infection |
| 01/16/2014 | US20140018287 Bridge-helix cap: target and method for inhibition of bacterial rna polymerase |
| 01/16/2014 | US20140017336 Co-administration of arsenic compounds and anti-herpes virus anti-virals |
| 01/16/2014 | US20140017330 Activated Nucleoside Analog Conjugates and Methods of Use Thereof |
| 01/16/2014 | US20140017323 Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| 01/16/2014 | US20140017317 Methods of treatment of solid tumors using coenzyme q10 |
| 01/16/2014 | US20140017315 Methods and compositions for treeating proliferative diseases |
| 01/16/2014 | US20140017308 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin |
| 01/16/2014 | US20140017253 RSPO3 Binding Agents and Uses Thereof |
| 01/16/2014 | US20140017249 Methods for improvement of beta cell function |
| 01/16/2014 | US20140017247 Composition for modulating the expression of cell adhesion molecules |
| 01/16/2014 | US20140017233 Biological markers for identifying patients for treatment with vegf antagonists |
| 01/16/2014 | US20140017232 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |